Previous Close | 17.51 |
Open | 17.67 |
Bid | 17.37 x 200 |
Ask | 17.47 x 200 |
Day's Range | 17.18 - 18.03 |
52 Week Range | 7.64 - 30.19 |
Volume | |
Avg. Volume | 904,517 |
Market Cap | 1.005B |
Beta (5Y Monthly) | -0.06 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Key Insights Given the large stake in the stock by institutions, Cullinan Therapeutics' stock price might be vulnerable...
Jennifer Michaelson, Chief Scientific Officer at Cullinan Therapeutics Inc (NASDAQ:CGEM), sold 63,606 shares of the company on May 7, 2024.
Strategic Developments and Financial Highlights Reflect Progress and Growth